Prevalence of autoimmune disease in moyamoya disease patients in Western Chinese population
- PMID: 25743224
- DOI: 10.1016/j.jns.2015.02.037
Prevalence of autoimmune disease in moyamoya disease patients in Western Chinese population
Abstract
The pathogenesis of moyamoya remains to be elucidated and an immunologic basis has been suggested. For gaining further insight into the pathogenesis of moyamoya, we explored the epidemiological characteristics of autoimmune disease in moyamoya disease (MMD) in Western Chinese population. Retrospective clinical characteristic analysis of patients with angiographically confirmed MMD was performed and compared with the general Chinese population. A significantly higher prevalence of autoimmune disease was observed, particularly type 1 diabetes mellitus (P<0.001, 7.0% vs 1.2%, χ(2) test) and Graves disease (P<0.001, 7.0% vs 0.34%, χ(2) test) in the general Chinese population. The overall prevalence of autoimmune disease in MMD was up to 31.0% (44/142). This study suggested higher overall prevalence of autoimmune disease in MMD in Western China when compared with the general Chinese population. The findings further supported that autoimmune abnormality might associate with MMD and autoimmune component to pathogenesis of moyamoya vasculopathy.
Keywords: Autoimmune disease; Comorbidity; Moyamoya disease; Pathogenesis; Prevalence; Risk factor.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.J Neurosurg. 2016 May;124(5):1215-20. doi: 10.3171/2015.4.JNS142936. Epub 2015 Sep 25. J Neurosurg. 2016. PMID: 26406790
-
Moyamoya disease in a primarily white, midwestern US population: increased prevalence of autoimmune disease.Stroke. 2013 Jul;44(7):1997-9. doi: 10.1161/STROKEAHA.111.000307. Epub 2013 May 7. Stroke. 2013. PMID: 23652271
-
Moyamoya and Inflammation.World Neurosurg. 2017 Apr;100:575-578. doi: 10.1016/j.wneu.2017.01.012. Epub 2017 Jan 16. World Neurosurg. 2017. PMID: 28093343
-
Cardiac manifestations in a western moyamoya disease population: a single-center descriptive study and review.Neurosurg Rev. 2021 Jun;44(3):1429-1436. doi: 10.1007/s10143-020-01327-x. Epub 2020 Jun 7. Neurosurg Rev. 2021. PMID: 32507930 Review.
-
Moyamoya angiopathy - Is there a Western phenotype?Br J Neurosurg. 2015;29(6):765-71. doi: 10.3109/02688697.2015.1096902. Epub 2015 Oct 16. Br J Neurosurg. 2015. PMID: 26473792 Review.
Cited by
-
Proteomic and metabolomic characterizations of moyamoya disease patient sera.Brain Behav. 2023 Dec;13(12):e3328. doi: 10.1002/brb3.3328. Epub 2023 Nov 14. Brain Behav. 2023. PMID: 37962021 Free PMC article.
-
Research progress on moyamoya disease combined with thyroid diseases.Front Endocrinol (Lausanne). 2023 Oct 11;14:1233567. doi: 10.3389/fendo.2023.1233567. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37900127 Free PMC article. Review.
-
Clinical value of the systemic immune-inflammation index in moyamoya disease.Front Neurol. 2023 Apr 20;14:1123951. doi: 10.3389/fneur.2023.1123951. eCollection 2023. Front Neurol. 2023. PMID: 37153657 Free PMC article.
-
Circulating Inflammatory Cytokine Associated with Poor Prognosis in Moyamoya Disease: A Prospective Cohort Study.J Clin Med. 2023 Jan 19;12(3):823. doi: 10.3390/jcm12030823. J Clin Med. 2023. PMID: 36769472 Free PMC article.
-
Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.Front Surg. 2022 Jul 1;9:929871. doi: 10.3389/fsurg.2022.929871. eCollection 2022. Front Surg. 2022. PMID: 35846951 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
